ACTA CARDIOLOGICA, cilt.61, sa.1, ss.7-11, 2006 (SCI-Expanded)
Objective - Haemolysis has long been recognized as one of the responses to cardiopulmonary bypass (CPB). Pentoxifylline (PTX), a methylxanthine derivative, has been known for many years for its haemorrheological properties. In this prospective, randomized study, we investigated whether a PTX treatment would reduce the haemolysis during CPB.